Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

The role of extracorporeal life support in acute myocarditis: a bridge to recovery?

Sanders DB, Sowell SR, Willis B, Lane J, Pierce C, Pophal S, Arabia FA, Nigro JJ.

J Extra Corpor Technol. 2012 Dec;44(4):205-9.

2.

The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device.

Pagani FD, Aaronson KD, Swaniker F, Bartlett RH.

Ann Thorac Surg. 2001 Mar;71(3 Suppl):S77-81; discussion S82-5.

PMID:
11265871
3.

Extracorporeal life support to terminate refractory ventricular tachycardia.

Tsai FC, Wang YC, Huang YK, Tseng CN, Wu MY, Chang YS, Chu JJ, Lin PJ.

Crit Care Med. 2007 Jul;35(7):1673-6.

PMID:
17507822
4.

Fulminant myocarditis in adults and children: bi-ventricular assist device for recovery.

Grinda JM, Chevalier P, D'Attellis N, Bricourt MO, Berrebi A, Guibourt P, Fabiani JN, Deloche A.

Eur J Cardiothorac Surg. 2004 Dec;26(6):1169-73.

PMID:
15541979
5.

Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.

Marasco SF, Lo C, Murphy D, Summerhayes R, Quayle M, Zimmet A, Bailey M.

Artif Organs. 2016 Jan;40(1):100-6. doi: 10.1111/aor.12496.

PMID:
25980985
6.

Extracorporeal life support in cardiogenic shock: Impact of acute versus chronic etiology on outcome.

Tarzia V, Bortolussi G, Bianco R, Buratto E, Bejko J, Carrozzini M, De Franceschi M, Gregori D, Fichera D, Zanella F, Bottio T, Gerosa G.

J Thorac Cardiovasc Surg. 2015 Aug;150(2):333-40. doi: 10.1016/j.jtcvs.2015.02.043.

PMID:
25869084
7.

Ventricular assist device support in children and adolescents with heart failure: the Children's Medical Center of Dallas experience.

Sharma MS, Forbess JM, Guleserian KJ.

Artif Organs. 2012 Jul;36(7):635-9. doi: 10.1111/j.1525-1594.2012.01443.x.

PMID:
22497304
8.

Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.

Noly PE, Kirsch M, Quessard A, Leger P, Pavie A, Amour J, Leprince P.

Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):49-55. doi: 10.1093/icvts/ivu072.

PMID:
24659551
9.

Extracorporeal life support in adults with hemodynamic collapse from fulminant cardiomyopathies: the chance of bridging to recovery.

Su TW, Tseng YH, Wu TI, Lin PJ, Wu MY.

ASAIO J. 2014 Nov-Dec;60(6):664-9. doi: 10.1097/MAT.0000000000000141.

PMID:
25232768
10.

Central nervous system complications during pediatric extracorporeal life support: incidence and risk factors.

Cengiz P, Seidel K, Rycus PT, Brogan TV, Roberts JS.

Crit Care Med. 2005 Dec;33(12):2817-24.

PMID:
16352965
11.

Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes.

Simon MA, Kormos RL, Murali S, Nair P, Heffernan M, Gorcsan J, Winowich S, McNamara DM.

Circulation. 2005 Aug 30;112(9 Suppl):I32-6.

12.

Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children.

Hetzer R, Loebe M, Potapov EV, Weng Y, Stiller B, Hennig E, Alexi-Meskishvili V, Lange PE.

Ann Thorac Surg. 1998 Nov;66(5):1498-506.

PMID:
9875742
13.

Myocardial calcification: a predictor of poor outcome for myocarditis treated with extracorporeal life support.

Stallion A, Rafferty JF, Warner BW, Ziegler MM, Ryckman FC.

J Pediatr Surg. 1994 Apr;29(4):492-4.

PMID:
8014800
14.

Mechanical circulatory support for the treatment of children with acute fulminant myocarditis.

Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL.

J Thorac Cardiovasc Surg. 2001 Sep;122(3):440-8.

15.

Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function.

Farrar DJ, Holman WR, McBride LR, Kormos RL, Icenogle TB, Hendry PJ, Moore CH, Loisance DY, El-Banayosy A, Frazier H.

J Heart Lung Transplant. 2002 May;21(5):516-21.

PMID:
11983540
16.

Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction.

Aoyama N, Imai H, Kurosawa T, Fukuda N, Moriguchi M, Nishinari M, Nishii M, Kono K, Soma K, Izumi T.

J Artif Organs. 2014 Mar;17(1):33-41. doi: 10.1007/s10047-013-0735-z.

PMID:
24162152
17.

Extracorporeal life support with an integrated left ventricular vent in children with a low cardiac output.

Sandrio S, Springer W, Karck M, Gorenflo M, Weymann A, Ruhparwar A, Loukanov T.

Cardiol Young. 2014 Aug;24(4):654-60. doi: 10.1017/S1047951113001017.

PMID:
23919969
18.

Predictors of 30-day mortality and outcome in cases of myocardial infarction with cardiogenic shock treated by extracorporeal life support.

Demondion P, Fournel L, Golmard JL, Niculescu M, Pavie A, Leprince P.

Eur J Cardiothorac Surg. 2014 Jan;45(1):47-54. doi: 10.1093/ejcts/ezt207.

PMID:
23616484
19.

Ventricular assist device support in children and adolescents as a bridge to heart transplantation.

Sharma MS, Webber SA, Morell VO, Gandhi SK, Wearden PD, Buchanan JR, Kormos RL.

Ann Thorac Surg. 2006 Sep;82(3):926-32.

PMID:
16928510
20.

Rapid onset of fulminant myocarditis portends a favourable prognosis and the ability to bridge mechanical circulatory support to recovery.

Atluri P, Ullery BW, MacArthur JW, Goldstone AB, Fairman AS, Hiesinger W, Acker MA, Woo YJ.

Eur J Cardiothorac Surg. 2013 Feb;43(2):379-82. doi: 10.1093/ejcts/ezs242.

PMID:
22564805

Supplemental Content

Support Center